Statistical Appendix

Overview of Statistical Methods Used for Biomarker Selection
There is no standard or agreed upon statistical methods used for ranking and selection of biomarkers related to a disease or a drug. Many different methods are used and they can potentially yield different rankings and selections. There are two different types of methods in general -one, an univariate method and the other is a multivariate method.
Univariate Method
Univariate methods consider one biomarker at a time without considering association with others. The most frequently used simple t-test belongs to this category. For a disease marker selection, for example, t-test compares two group means between the normal and diseased samples. This is equivalent to the use of Pearson's correlation coefficient between the biomarker expression ("x") and an indicator variable ("y") coded as 0's for normal and 1's for diseased samples. The same result can be obtained by considering the simple linear regression between the "x" and "y" and test the regression coefficients for significance (i.e. whether the regression coefficient is significantly different from zero). The statistic used in this model is another t statistic formed by the ratio of the estimated regression coefficient to its standard error. The actual ranking of biomarkers can be done by corresponding p-values and some cut point can be used for the final selection. The technique used in this study also adjust the p-values for the multiplicity of the testing using the concept of false discovery rate (FDR). The idea of Ordinary least squares or logistic regression, however, can have a serious problem especially when the data is of high dimensional and as a result the biomarker expressions are highly correlated. This is a well known multi-collinearity problem for linear regression and OLS' regression coefficients can be very misleading since their standard errors are so large that sometimes they even have wrong signs in their estimates. The same is true for logistic regression for classification and we can not rely on their coefficients and p-values for the ranking and selection of the biomarkers. These models are unstable under multi-collinearity and are of high variance structure.
A shrinkage method of estimation such as principal component regression (PCR), partial least squares (PLS) and ridge regression (RR) can bypass this multi-collinearity problem by regularization of the estimation process (1). They may introduce a small bias but can reduce the variance of the estimated coefficients appreciably and hence are more stable.
We have used partial least squares (PLS) regression and its discriminant analysis (PLS-DA) to deal with high dimensional biomarker selection and found them very competitive with other methods of shrinkage estimation. The PLS-DA is simply PLS applied to a categorical response variable. For a binary response, it is typically coded as 0 or 1 but other scaling of the response does not alter the ranking of the regression coefficients and hence interpretation of the result remains the same. The software package SIMCA (2) implemented PLS and PLS-DA in a very user friendly manner with an excellent graphical user interface. We found the package very useful for high dimensional data analysis in general. There is a recent study comparing different shrinkage methods and currently active research is being done to improve the accuracy and flexibility of ridge regression to high dimensional biomarker selection (3).
Nonlinear models such as decision trees and neural networks can improve the accuracy of their predictions by adopting nonlinearity but are of high variance structure and can be unstable as well. Decision tree algorithms are unstable at times since variable selection is done in a stepwise manner and is of discrete nature (greedy algorithm).
This can be true for any stepwise variable (biomarker) selection algorithms.
Neural networks use many parameters in the estimation process (in many cases overparametrized) and a trade off can be again instability of the model. One interesting computer intensive method called Random Forest (4) is based on the bootstrap aggregation of the many (> 500 for example) decision tree models and is a very promising tool for high dimensional biomarker selection. Our limited experience showed that the PLS coefficients gave similar rankings of the biomarkers to the Random Forest in many cases of high dimensional data.
Model Validation.
Validation of a prediction model can be done externally on a separate test data or internally using a cross validation. Typically cross validation is applied to come up with a best performing model e.g. to minimize a performance measure such as predicted residual sums of squares for a regression model. Once a cross validated performance is obtained, the statistical significance of the performance measure is obtained by a permutation test. The permutation test in this case is to randomly permute the labels of the response part of the data to assess the significance of the actual performance measure against those obtained from random permutations of labels. If none of the models from the 100 different random permutations of the labels of the response showed better performance than the model from original data then we can conclude the model is significant at P less than 0.01. Our approach of model validation was based on combining the ideas of the cross validation and the permutation test.
Data analysis strategy used in the stusy.
The ranking and selection of biomarkers is not a pure statistical exercise but should be a collaborative effort between statisticians and scientists. We could obtain a ranking of Hence a regression coefficient essentially measures the partial correlation between an average biomarker in a cluster with COPD that is adjusted for all other cluster averages.
Description of the analytes included in the micro-arrays.
The total number of analytes included on arrays 1-5. Note data from CRP on array 5 was not useable due to CRP levels well above the upper detection limit of the assay which resulted in a 'Hook effect". 
